Literature DB >> 3041139

Microinjection of oxytocin into limbic-mesolimbic brain structures disrupts heroin self-administration behavior: a receptor-mediated event?

R Ibragimov, G L Kovács, G Szabó, G Telegdy.   

Abstract

The systemic injection of oxytocin (OXT) decreases the self-administration of heroin in heroin-tolerant rats. Since OXT-ergic binding sites are present in limbic and mesolimbic brain regions, the effects of intracerebral microinjections of OXT were investigated. In heroin-tolerant rats, the microinjection of OXT (2 ng) into the anterodorsal part of the nucleus accumbens or into the ventral hippocampus disrupted the self-administration of heroin. The effect of intrahippocampal microinjections lasted longer than that of intraaccumbens injections. The administration of N alpha-acetyl-(2-0-methyltyrosine)-oxytocin (ACME-OXT), an inhibitor of oxytocin receptors, prevented the disruptive effect of intrahippocampal OXT injections on heroin self-administration. It is concluded that limbic-mesolimbic brain structures have an essential role in the expression of the disruptive action of OXT on heroin self-administration. It appears that OXT-ergic binding sites mediate the effects of OXT.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3041139     DOI: 10.1016/0024-3205(87)90205-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  14 in total

1.  Oxytocin Reduces Cigarette Consumption in Daily Smokers.

Authors:  Kathryne Van Hedger; Meredith J Kushner; Royce Lee; Harriet de Wit
Journal:  Nicotine Tob Res       Date:  2019-05-21       Impact factor: 4.244

2.  Effects of Intranasal Oxytocin on Stress-Induced Cigarette Craving in Daily Smokers.

Authors:  Kathryne Van Hedger; Anya K Bershad; Royce Lee; Harriet de Wit
Journal:  Nicotine Tob Res       Date:  2020-01-27       Impact factor: 4.244

3.  Intracranial self-stimulation of the paraventricular nucleus of the hypothalamus: increased faciliation by morphine compared to cocaine.

Authors:  Eric E Ewan; Thomas J Martin
Journal:  Anesthesiology       Date:  2012-05       Impact factor: 7.892

Review 4.  Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date.

Authors:  Mary R Lee; Matthew C H Rohn; Gianluigi Tanda; Lorenzo Leggio
Journal:  CNS Drugs       Date:  2016-02       Impact factor: 5.749

Review 5.  Oxytocin for the treatment of drug and alcohol use disorders.

Authors:  Mary R Lee; Elise M Weerts
Journal:  Behav Pharmacol       Date:  2016-12       Impact factor: 2.293

6.  Antagonism of mGlu2/3 receptors in the nucleus accumbens prevents oxytocin from reducing cued methamphetamine seeking in male and female rats.

Authors:  Aurelien Bernheim; Kah-Chung Leong; Carole Berini; Carmela M Reichel
Journal:  Pharmacol Biochem Behav       Date:  2017-09-01       Impact factor: 3.533

Review 7.  Oxytocin and opioid addiction revisited: old drug, new applications.

Authors:  Panos Zanos; Polymnia Georgiou; Carol Weber; Fiona Robinson; Christos Kouimtsidis; Ramin Niforooshan; Alexis Bailey
Journal:  Br J Pharmacol       Date:  2017-04-06       Impact factor: 8.739

Review 8.  The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction.

Authors:  James P Burkett; Larry J Young
Journal:  Psychopharmacology (Berl)       Date:  2012-08-11       Impact factor: 4.530

Review 9.  Early adverse experience and substance addiction: dopamine, oxytocin, and glucocorticoid pathways.

Authors:  Sohye Kim; Stephanie Kwok; Linda C Mayes; Marc N Potenza; Helena J V Rutherford; Lane Strathearn
Journal:  Ann N Y Acad Sci       Date:  2016-08-10       Impact factor: 5.691

Review 10.  Oxytocin treatment for alcoholism: Potential neurocircuitry targets.

Authors:  Joanna Peris; Madeline R Steck; Eric G Krause
Journal:  Neuropharmacology       Date:  2020-04-15       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.